Home » Press Release » 2013 » February 28, 2013

February 28, 2013

Alethia Biotherapeutics Announces Notice of Allowance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT

Alethia 130228 EN